On March 5, The Crowd – U.K.’s leading CSR, innovation, and sustainability network – will have Novozymes’ CEO, Peder Holk Nielsen, headlining. Attendance is free.

As noted recently by the New York Times in a front-page feature, the world-leading biotech company, headquartered out of Copenhagen, is wielding the power of the small – enzymes and microbes – to tackle the biggest problems of all – global climate change, ecosystem protection and the Sustainable Development Goals.

Peder has used the SDGs to help shape the company’s long-term targets and purpose of finding biological answers for better lives in a growing world. Among those targets is an ambition to reach six billion people with the company’s biological solutions, deliver ten transformative innovations, catalyse five global partnerships for change, and save 100 million tons of CO2 through use of the company’s products – all by 2020.

Peder will be sharing his experience and knowledge with The Crowd, demonstrating the impact that committed, passionate leadership can have in making business a positive force for good in the world. It is an inspiring story of how the SDGs can help prioritise, energise and focus business, open doors at the highest political levels, attract the right partners and accelerate competitive advantage.

Join The Crowd on March 5, for a thought-provoking evening with Peder in conversation with Axel Threlfall, Editor-at-Large from Reuters. Attendance is free, however, subject to application and approval.


* Note! This event is not a DUCC event, but one we have kindly offered to publish on behalf of our network. DUCC cannot be held liable for anything related to this. Thus any comments, questions or reclamation please contact the organiser directly.


Terms, Conditions & Cancellation Policy
Subject to terms & conditions.

Go To Top